Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Pimecrolimus (SDZ-ASM 981), a calcineurin inhibitor immunosuppressant, binds to the receptor macrophilin-12 (FKBP-12) forming a complex that blocks the calcium-dependent signal transduction cascade mediated by calcineurin.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 34.00 | |
10 mg | In stock | $ 54.00 | |
25 mg | In stock | $ 63.00 | |
50 mg | In stock | $ 72.00 | |
100 mg | In stock | $ 127.00 | |
200 mg | In stock | $ 189.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 54.00 |
Description | Pimecrolimus (SDZ-ASM 981), a calcineurin inhibitor immunosuppressant, binds to the receptor macrophilin-12 (FKBP-12) forming a complex that blocks the calcium-dependent signal transduction cascade mediated by calcineurin. |
In vitro | Pimecrolimus effectively alleviates allergic symptoms in a variety of (allergic) animals. Within the context of both the acute allergic dermatitis low-magnesium hairless rat model and the moderate allergic contact dermatitis mouse model, Pimecrolimus inhibits inflammatory responses and pruritic (itching) symptoms. |
In vivo | In mast cells, Pimecrolimus inhibits the transcription and synthesis of cytokines, while simultaneously promoting the release of 5-hydroxytryptamine and β-hexosaminidase. In T lymphocytes, Pimecrolimus suppresses activation by inhibiting phosphatase activity, thereby blocking T-cell activation. |
Synonyms | SDZ-ASM 981, ASM 981 |
Molecular Weight | 810.45 |
Formula | C43H68ClNO11 |
CAS No. | 137071-32-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 1 mg/mL (insoluble or slightly soluble)
Ethanol: 93 mg/mL (114.8 mM)
DMSO: 93 mg/mL (114.8 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Pimecrolimus 137071-32-0 Others mast cells T-cells SDZ-ASM 981 ASM-981 ASM 981 atopic dermatitis oral erosive lichen planus Phosphatase Inhibitor inhibit SDZ-ASM981 anti-inflammatory orally active inflammatory skin diseases SDZ-ASM-981 ASM981 inhibitor